BRCA1 and ovarian cancer: The study population is relatively small (n = 59), although this is a common feature in previous studies of BRCA1/2 positive populations, and is not broadly representative as it contains larger proportions of key subgroups (older age, non-Hispanic European ancestry, and family history of breast and ovarian cancer).